Marthe Bosuandole

  • A health worker handles a vial of the Bavarian Nordic A/S Jynneos monkeypox vaccine at the Calit Medical Center in Tel Aviv, Israel on Sunday, July 31, 2022. As health authorities all over the globe search for ways to stop the monkeypox outbreak, investors are snapping up shares of companies that could benefit from the race to quell the disease. Photographer: Kobi Wolf/Bloomberg via Getty ImagesHealth

    Bavarian Nordic gearing up to produce 10 million doses of mpox vaccine as ‘further imported cases’ in Europe are coming, WHO warns

    By Camille Bas-Wohlert, Marthe Bosuandole, and others